Therapeutics company Algeta ASA has applied for listing on the Oslo Stock Exchange. The company raised NOK 185m in series-A financing from a consortium of investors, including HealthCap, Advent Venture Partners, SR One, and existing investors, Selvaag Venture Capital, NorgesInvestor, Marlin Verdi AS and several smaller investors in 2005. .
Asset is reportedly due to come to market in 2021, with the sale process most likely starting in H1
Redalpine has led a series-A funding round for Germany-headquartered pet healthcare startup Felmo.
GP intends to boost the company's growth and consolidate its market position in the Benelux and DACH regions
GP is deploying equity via WMS III and is investing with future managing director Holger Schmitz